A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 06:27
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Putin praises Musk as ‘outstanding person’ days after report Tesla boss stopped Ukrainian attack
HYAS Unveils EyeSpy Proof of Concept for New Type of Polymorphic, Intelligent and Fully Autonomous Malware
NASA discover signs of water and carbon on asteroid sample
Westinghouse Awarded Trio of Grants from UK Nuclear Fuel Fund
Apple Could See a Hit to Profit if Google Loses DOJ Search Lawsuit: Analyst
Explainer-GM-owned Cruise's wrong turn could slow robotaxi push
These Stocks Are Moving the Most Today: Workday, Las Vegas Sands, Fluence Energy, NetApp, Jabil, and More
Musk Calls for AI ‘Regulatory Structure,’ Warns Congress of Risk